The CureVac stock has seen significant price gains in recent weeks, indicating a positive market development. However, analysts’ opinions remain divided, creating uncertainty in the market conditions. Here are some key aspects that shed light on this situation:
Current Price Development
- Price Increase: The CureVac stock has continuously recovered over the past weeks. On April 24, 2025, it crossed the 50-day line and was quoted at 2.88 EUR. On April 28, 2025, the price was 2.98 EUR, which represents an increase of 5.64% compared to the previous day.
- Long-Term Trend: Despite the recent gains, the stock has been in a long-term downward trend since February 25, 2025.
Analyst Opinion
- Consensus Recommendation: Analysts generally recommend increasing positions in the stock, indicating a positive assessment of future developments. The average price target is 5.72 EUR, representing a potential increase of over 100% compared to the current price.
- Division of Opinion: Despite the positive recommendations, analysts’ opinions remain divided, suggesting uncertainties in the market. Some analysts may have concerns regarding the long-term sustainability of the price increase.
Technical Analysis
- Bullish Signals: Technical indicators such as moving averages, MACD oscillator, and Parabolic SAR indicator show predominantly bullish signals. Out of a total of 30 assessment parameters, 22 are classified as bullish, indicating an upward trend.
- Uncertainty: The chart technical analysis shows that investors remain cautious and are waiting for clear trend reversals. The stock is in an early phase of its projects, which can lead to uncertainties.
Forecast
- Short-Term Forecast: For December 2025, an average price of about 3.43 USD is expected, indicating further recovery.
- Long-Term Uncertainty: Despite positive short-term forecasts, the long-term development remains uncertain as CureVac’s projects are still in an early phase and market reactions can vary.
In conclusion, the CureVac stock currently shows strong price development, but the market condition remains uncertain, as analysts’ opinions are divided and the long-term sustainability of the price increase remains unclear.